Food chain problems 2015 - Webinar on Setting Up and Running a Tougher Supplier Audit Program
Date2015-10-21
Deadline2015-10-20
VenueFremont, USA - United States
KeywordsSupplier management training; Advantages of audit program; Supplier Audit Procedures
Websitehttps://bit.ly/1MKfNeT
Topics/Call fo Papers
Overview:
The last few years have seen the U.S. FDA come under increasing negative public scrutiny. High profile drug recalls, food chain problems and contamination, import problems, resignations. Now a new commissioner vows no more "business as usual". Data in submissions and decisions rendered will be more science based.
Most Warning Letters will not have an initial judicial review, resulting in more and faster Warning Letter filings. Larger, higher profile companies are coming under FDA investigation activities. A key area gaining attention is a company’s suppliers, for both services and products / components. Why needed? FDA expectations? How are successful companies meeting this challenge. Tools that need to be put in place or enhanced. Getting supplier buy-in. Coping with "rogue" suppliers.
Areas Covered in the Session:
Regulatory "Hot Buttons"
Classify suppliers
Supplier requirements by "classification"
The site audit
Types of remote audits
Maintaining the relationship
Who Will Benefit:
Senior Management, Project Leaders, Internal / External Consultants
Mid-level management and supervisory personnel
Corporate and site coordinators
Regulatory Affairs
Quality systems personnel / QAE
R&D and engineering staff
Purchasing personnel
New product development personnel
Speaker Profile:
John E. Lincoln is a medical device and regulatory affairs consultant. He has helped companies to implement or modify their GMP systems and procedures, product risk management, U.S. FDA responses. In addition, he has successfully designed, written and run all types of process, equipment and software qualifications/validations, which have passed FDA audit or submission scrutiny, and described in peer-reviewed technical articles, and workshops, world wide. John has also managed pilot production, regulatory affairs, product development/design control, 510(k) submissions, risk management per ISO 14971, and projects; with over 28 years of experience in the FDA-regulated medical products industry - working with start-ups to Fortune 100 companies, including Abbott Laboratories, Hospira, Tyco/Mallinckrodt. He is a graduate of UCLA.
Contact Detail:
NetZealous LLC DBA Compliance4All,
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA.
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com
http://www.compliance4all.com/
Event Link: http://bit.ly/1MKfNeT
The last few years have seen the U.S. FDA come under increasing negative public scrutiny. High profile drug recalls, food chain problems and contamination, import problems, resignations. Now a new commissioner vows no more "business as usual". Data in submissions and decisions rendered will be more science based.
Most Warning Letters will not have an initial judicial review, resulting in more and faster Warning Letter filings. Larger, higher profile companies are coming under FDA investigation activities. A key area gaining attention is a company’s suppliers, for both services and products / components. Why needed? FDA expectations? How are successful companies meeting this challenge. Tools that need to be put in place or enhanced. Getting supplier buy-in. Coping with "rogue" suppliers.
Areas Covered in the Session:
Regulatory "Hot Buttons"
Classify suppliers
Supplier requirements by "classification"
The site audit
Types of remote audits
Maintaining the relationship
Who Will Benefit:
Senior Management, Project Leaders, Internal / External Consultants
Mid-level management and supervisory personnel
Corporate and site coordinators
Regulatory Affairs
Quality systems personnel / QAE
R&D and engineering staff
Purchasing personnel
New product development personnel
Speaker Profile:
John E. Lincoln is a medical device and regulatory affairs consultant. He has helped companies to implement or modify their GMP systems and procedures, product risk management, U.S. FDA responses. In addition, he has successfully designed, written and run all types of process, equipment and software qualifications/validations, which have passed FDA audit or submission scrutiny, and described in peer-reviewed technical articles, and workshops, world wide. John has also managed pilot production, regulatory affairs, product development/design control, 510(k) submissions, risk management per ISO 14971, and projects; with over 28 years of experience in the FDA-regulated medical products industry - working with start-ups to Fortune 100 companies, including Abbott Laboratories, Hospira, Tyco/Mallinckrodt. He is a graduate of UCLA.
Contact Detail:
NetZealous LLC DBA Compliance4All,
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA.
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com
http://www.compliance4all.com/
Event Link: http://bit.ly/1MKfNeT
Other CFPs
- Webinar on Regulatory Aspects of Advanced Therapy Medicinal Products in the EU
- Webinar on A second look at 510(k) changes
- Webinar on Combination Products: FDA's Final Rule for GMP Requirements and Introduction and Expectations for "Combo" Products
- Webinar on Export Letters of Credit
- Webinar on Building a Lean Culture
Last modified: 2015-08-25 18:35:51